CogState Limited (ASX: CGS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
CogState Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
CogState Limited (ASX: CGS)
Latest News
Share Market News
Here's why the Cogstate (ASX:CGS) share price is up 5% today
Share Gainers
Why the Cogstate (ASX:CGS) share price is surging 23% today
Healthcare Shares
Here's why the Actinogen Medical (ASX: ACW) share price is up 20%
Ask a Fund Manager
4 ASX shares to gain exposure to international market growth: fund manager
Share Gainers
Why Cogstate, Contact Energy, EML, & OM Holdings are pushing higher
Share Gainers
Why the Cogstate (ASX:CGS) share price is rocketing 73% higher
Share Market News
Why the Cogstate (ASX:CGS) share price is rising today
Share Market News
Why the CogState (ASX:CGS) share price shot 8% today
Share Market News
What's moving the Cogstate (ASX:CGS) share price today?
Share Market News
CogState (ASX:CGS) share price up 44% today and a mind-blowing 207% in 2020
Share Market News
ASX stock of the day: CogState (ASX:CGS) shares up 24%. Here's why
Share Gainers
Why Alcidion, Blackmores, Boral, & CogState shares are pushing higher
Frequently Asked Questions
-
No, Cogstate does not pay dividends at this stage.
-
Cogstate Ltd listed on the ASX on 13 February 2004.
CGS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About CogState Limited
Cogstate Ltd (ASX: CGS) is a neuroscience technology company specialising in brain health assessments. The principal activity of the company is the sale of technology and services to measure cognition.
The company provides licensed digital tests for health professionals and medical researchers. Its services include scientific consultancy, project management, data management, statistical analysis, and reporting. Cogstate generates the bulk of its revenue from its clinical trials segment.
Cogstate's technology has been used in more than 2,000 scientific and clinical trial studies. These include fields such as Alzheimer's, depression, and bipolar disorder research as well as studies investigating cognitive impairment in athletes as a result of concussive injuries.
